Crossmark

A comprehensive analysis identified BECN1 as potential diagnostic biomarker for homotypic cell-in-cell in non-small cell lung cancer through integrated bioinformatics and clinical validation approaches

Crossref DOI link: https://doi.org/10.1007/s12672-026-04541-z

Published Online: 2026-01-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Xiaona

Guo, Rui

Qiang, Lei

Huang, Xiaozhong

Wang, Ya’nan

Li, Dongxuan

Yang, Jun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82102726)
License Information

Text and Data Mining valid from 2026-01-31

Version of Record valid from 2026-02-25
More Information

Article History

Received: 25 August 2025

Accepted: 27 January 2026

First Online: 31 January 2026

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and approved by the biomedical Ethics Committee of faculty of medicine Xi’an Jiaotong University (No.2021.954). Informed consent was obtained from all individual participants included in the study.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below